<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2709-7927</journal-id>
<journal-title><![CDATA[Acta Médica del Centro]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd centro]]></abbrev-journal-title>
<issn>2709-7927</issn>
<publisher>
<publisher-name><![CDATA[Hospital Provincial Clínico Quirúrgico Universitario Arnaldo Milián Castro]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2709-79272022000400665</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización de pacientes con síndrome adénico]]></article-title>
<article-title xml:lang="en"><![CDATA[Characterization of patients with adenoid syndrome]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mederos Muro]]></surname>
<given-names><![CDATA[Edelkis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reyes Hernández]]></surname>
<given-names><![CDATA[Dianelí Lorely]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Estupiñán Martínez]]></surname>
<given-names><![CDATA[Oscar Rogelio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cruz Vizcaíno]]></surname>
<given-names><![CDATA[Bárbaro Reimundo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Provincial Clínico Quirúrgico Universitario &#8220;Arnaldo Milián Castro&#8221;  ]]></institution>
<addr-line><![CDATA[Santa Clara Villa Clara]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<volume>16</volume>
<numero>4</numero>
<fpage>665</fpage>
<lpage>678</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S2709-79272022000400665&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S2709-79272022000400665&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S2709-79272022000400665&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el aumento de volumen de los ganglios linfáticos produce un grupo de síntomas y signos que constituyen el síndrome adénico. Se denomina adenopatía a la enfermedad del ganglio linfático.  Objetivo:  caracterizar a los pacientes que ingresaron con síndrome adénico en el Servicio de Medicina Interna en el período de 2016 a 2018.  Métodos:  se realizó un estudio descriptivo de tipo transversal. La población estuvo constituida por los pacientes que ingresaron con diagnóstico de síndrome adénico a los que se les realizó biopsia ganglionar con diagnóstico clínico y patológico concluyente, con un total de 103 pacientes.  Resultados:  predominaron las adenopatías malignas en el 74,8%, la edad media de los pacientes fue de 57,48±17,25 años y predominó el sexo masculino (60,2%), las metástasis ganglionares fueron las más frecuentes (33%), el cáncer de pulmón, con nueve pacientes, encabezó las causas de metástasis ganglionar y predominaron las adenopatías localizadas con un 68% (el 36% fue de localización cervical). En los pacientes con adenopatías malignas predominó la edad mayor de 50 años, el sexo masculino, el color blanco de la piel, la localización supraclavicular, la presencia de síntomas acompañantes como la pérdida de peso y la sudoración y de signos como la palidez cutaneomucosa y la esplenomegalia.  Conclusiones:  predominaron las adenopatías malignas, la localización cervical, los pacientes con edad media próxima al adulto mayor, masculinos y blancos. Las metástasis fueron más frecuentes en el cáncer de pulmón. La pérdida de peso, la sudoración, la palidez y la esplenomegalia fueron los síntomas y signos más hallados.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  enlarged lymph nodes produce a group of symptoms and signs that constitute the adenopathy syndrome. Lymph node disease is called adenopathy.  Objective:  to characterize patients who were admitted with adenoid syndrome to the Internal Medicine Service in the period from 2016 to 2018.  Methods:  a descriptive cross-sectional study was performed. The population consisted of patients admitted with a diagnosis of adenoid syndrome who underwent lymph node biopsy with a conclusive clinical and pathological diagnosis, with a total of 103 patients.  Results:  malignant adenopathies predominated in 74.8%, the average age of the patients was 57.48±17.25 years and male sex predominated (60.2%), lymph node metastases were the most frequent (33%), lung cancer, with nine patients, headed the causes of lymph node metastases and localized adenopathies predominated with 68% (36% were of cervical location). In patients with malignant lymphadenopathies, age over 50 years, male sex, white skin color, supraclavicular location, presence of accompanying symptoms such as weight loss and sweating and signs such as cutaneomucosal pallor and splenomegaly predominated.  Conclusions:  malignant adenopathies, cervical location, patients with average age close to elderly, male and white were predominant. Metastases were more frequent in lung cancer. Weight loss, sweating, pallor and splenomegaly were the most frequently found symptoms and signs.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[síndrome adénico]]></kwd>
<kwd lng="es"><![CDATA[linfaadenopatía]]></kwd>
<kwd lng="es"><![CDATA[ganglio linfático]]></kwd>
<kwd lng="es"><![CDATA[metástasis]]></kwd>
<kwd lng="es"><![CDATA[biopsia]]></kwd>
<kwd lng="en"><![CDATA[adenoid syndrome]]></kwd>
<kwd lng="en"><![CDATA[lymphadenopathy]]></kwd>
<kwd lng="en"><![CDATA[lymph node]]></kwd>
<kwd lng="en"><![CDATA[metastasis]]></kwd>
<kwd lng="en"><![CDATA[biopsy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasr]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Skrabek]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Histologic Examination and Ancillary Studies in Lymph Node Pathology]]></article-title>
<source><![CDATA[Lymph Node Pathology for Clinicians]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Cham ]]></publisher-loc>
<publisher-name><![CDATA[Springer Nature Switzerland AG]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasr]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Perry]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Skrabek]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Basic Concepts in Lymph Node Pathology]]></article-title>
<source><![CDATA[Lymph Node Pathology for Clinicians]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Cham ]]></publisher-loc>
<publisher-name><![CDATA[Springer Nature Switzerland AG]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Soca]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfomas y otrasenfermedades ganglionares]]></article-title>
<source><![CDATA[Farreras R. Medicina Interna]]></source>
<year>2020</year>
<edition>19</edition>
<page-range>1671-2</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Mc-Graw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bravo Moncayo]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Uricoechea]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del paciente con linfadenopatías y esplenomegalia]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Vargas-Uricoechea]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Texto de Medicina Interna]]></source>
<year>2021</year>
<edition>2</edition>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Asociación Colombiana de Endocrinología, Diabetes y Metabolismo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vargas Viveros]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado Monroy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenomegalia]]></article-title>
<source><![CDATA[Rev Fac Med (Méx)]]></source>
<year>2011</year>
<volume>54</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>10-23</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pastor]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenopatías, esplenomegalia]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Laso]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<source><![CDATA[Diagnóstico diferencial en Medicina Interna]]></source>
<year>2013</year>
<edition>3</edition>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armitage]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aproximación al paciente con adenopatías y esplenomegalia]]></article-title>
<source><![CDATA[Goldman-Cecil. Tratado de Medicina Interna]]></source>
<year>2017</year>
<edition>25</edition>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenopatías]]></article-title>
<source><![CDATA[Semiología]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Santiago de Chile ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Chile]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moya]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Corral]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pascual]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Casanova]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[López-Quiñones]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenopatías]]></article-title>
<collab>Grupo Científico DTM</collab>
<source><![CDATA[Green Book. Diagnóstico y Tratamiento Médico]]></source>
<year>2019</year>
<edition>7</edition>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Marbán]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud</collab>
<source><![CDATA[Anuario Estadístico de Salud 2020]]></source>
<year>2021</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Özkan]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Göret]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Özdemir]]></surname>
<given-names><![CDATA[ZT]]></given-names>
</name>
<name>
<surname><![CDATA[Yanik]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Göret]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
<name>
<surname><![CDATA[Dogan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of peripheral lymphadenopathy with excisional biopsy: six-year experience]]></article-title>
<source><![CDATA[Int J Clin Exp Pathol]]></source>
<year>2015</year>
<volume>8</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>15234-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olu-Eddo]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Ohanaka]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peripheral lymphadenopathy in Nigerian adults]]></article-title>
<source><![CDATA[J Pak Med Assoc]]></source>
<year>2006</year>
<volume>56</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>405-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bosch]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Coloma]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Donate]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Colomo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Doti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Jordán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2014</year>
<volume>93</volume>
<numero>16</numero>
<issue>16</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pruritus and Systemic Disease]]></article-title>
<source><![CDATA[Medscape]]></source>
<year>01/1</year>
<month>0/</month>
<day>20</day>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Medscape]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintero Sierra]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Teruel Herrero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Padrón]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Concepción Fernández]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Romero González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Macia Pérez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización del linfoma de Hodgkin en los pacientes adultos]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2019</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Zúñiga]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar-Andrade]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Vera]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Augusto-Pacheco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Báez-Islas]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Bates-Martín]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma de Hodgkin]]></article-title>
<source><![CDATA[Rev Hematol Mex]]></source>
<year>2019</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>124-30</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcés Ortega]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[González Bracho]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz Benavides]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Quijije Castro]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pacuruco Cajas]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez Maita]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma de Hodgkin y no Hodgkin: desde una perspectiva molecular, diagnóstica y terapéutica]]></article-title>
<source><![CDATA[Arch Venez Farmacol Ter]]></source>
<year>2021</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>310-21</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Biopsia de ganglio centinela]]></article-title>
<source><![CDATA[Instituto Nacional del Cáncer]]></source>
<year>25/0</year>
<month>6/</month>
<day>20</day>
<publisher-loc><![CDATA[Bethesda (MD) ]]></publisher-loc>
<publisher-name><![CDATA[NIH (US)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nazario Dolz]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez Matos]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo Toledo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Miyares Peña]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Garbey Nazario]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Algunas especificidades en torno al cáncer de pulmón]]></article-title>
<source><![CDATA[Rev Cub Med Mil]]></source>
<year>2021</year>
<volume>50</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uriburu]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Rostagno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Maciel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Noblía]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rafailovici]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Coló]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso Intersociedades 2018. Ganglio centinela positivo en estadios iniciales de cáncer de mama]]></article-title>
<source><![CDATA[Rev Arg Mastol]]></source>
<year>2018</year>
<volume>36</volume>
<numero>136</numero>
<issue>136</issue>
<page-range>12-56</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
